Triangle Chapter Speaker Series

Opus Genetics is a groundbreaking gene therapy company for inherited retinal diseases backed by Foundation Fighting Blindness through the RD Fund. This will be a unique experience to hear from Dr. Scott Greenwald, Director of Gene Therapy, and Dr. Lilia Koza, Associate Scientist, who will be providing an engaging discussion centered around all things gene therapy. This will include an overview of adeno-associated virus-based gene therapy and its development from preclinical testing to clinical trials. Please arrive with an empty stomach for an optional mix and mingle at 6:00 PM in the lounge at Opus Genetics. We cannot wait to see you there!